Roche Holding AG (ROP.SW)

Swiss: ROP.SW · Real-Time Price · USD

367.40

+6.50 (1.80%)

At close: Aug 19, 2026, 3:31 PM

1.80% (1D)

No data available

Bid	n/a
Market Cap	292.73B
Revenue (ttm)	62.96B
Net Income (ttm)	12.34B
Beta	0.35
EPS (ttm)	15.34
PE Ratio (ttm)	23.95
Forward PE	16.77
P/B (ttm)	8.95
P/S (ttm)	4.65
Earnings Date	Jan 28, 2027

Ask	n/a
Volume	936,035
Avg. Volume (20D)	980,736
Open	360.20
Previous Close	360.90
Day's Range	360.20 - 368.20
52-Week Range	252.20 - 374.90
Analyst	n/a
Price Target	n/a
Dividends	$9.8 (2.72%)
Ex-Dividend Date	Mar 12, 2026

About ROP.SW

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for ...

[Read more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Apr 3, 1995

Employees n/a

Stock Exchange Swiss

Ticker Symbol ROP.SW

Website https://www.roche.com

Full Company Profile

Financial Performance

In 2025, Roche's revenue was 63.36B, an increase of 1.54% compared to the previous year's 62.4B. Earnings were 12.88B, an increase of 55.61%.

Financial numbers in CHF Financial Statements

Earnings Surprise

Roche has released their quarterly earnings on Jul 21, 2021:

Revenue of n/a misses estimates by $0, with NaN% YoY growth.

EPS of 3.49 misses estimates by -6.75, with -47.04% YoY decline.

Next Earnings Release

Roche Holding AG is scheduled to release its earnings on Jan 28, 2027, during market hours.
Analysts project revenue of ... Upgrade

News

Just now · Exec Edge

Real Parkinson’s Disease Hope from Jupiter Neurosciences

By Mike Sheikh Parkinson’s Disease has challenged drug developers for generations, but Jupiter Neurosciences (NASDAQ: JUNS) is betting that a streamlined clinical plan can break the stalemate. The mar...

2 days ago · MarketBeat

Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates

Recursion Pharmaceuticals (NASDAQ:RXRX) is using artificial intelligence to generate and analyze biological data in an effort to improve drug discovery, advance internal therapeutic programs and suppo...